Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 2,830,230	$ 3,071,887
Trade accounts receivable less allowances of approximately $45,000 and $93,000, respectively	2,968,136	4,413,656
Receivables due from affiliated companies	1,029,021	536,402
Inventories, net	8,763,691	7,367,894
Prepaid expenses and other current assets	773,663	621,107
Deferred tax asset	45,714	64,665
Total Current Assets	16,410,455	16,075,611
Property, plant and equipment, net	5,116,274	5,116,441
Other Assets:
Trademarks, trade names, royalty rights, and patents, net	902,921	920,269
Other assets	129,562	130,803
Total Other Assets	1,032,483	1,051,072
Total Assets	22,559,212	22,243,124
Current Liabilities:
Accounts payable - trade	1,491,157	1,013,829
Dividends payable	440,016
Current portion of long term debt	416,240	414,525
Income taxes payable	115,294	119,943
Accrued expenses payable	759,217	1,067,355
Total Current Liabilities	3,221,924	2,615,652
Deferred tax liability	216,553	237,635
Long term debt, less current portion	1,012,419	1,117,761
Total Liabilities	4,450,896	3,971,048
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,864,888 and 8,749,888 shares issued	88,649	87,499
Additional paid in capital	8,855,060	8,805,460
Less cost of common stock in treasury, 64,574 and 79,941 shares, respectively	(52,529)	(65,029)
Accumulated other comprehensive loss	(270,617)	(266,456)
Retained earnings	9,265,710	9,482,128
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	17,886,273	18,043,602
Noncontrolling interest	222,043	228,474
Total Shareholders' Equity	18,108,316	18,272,076
Total Liabilities and Shareholders' Equity	$ 22,559,212	$ 22,243,124